JMP Securities Covers Mostly Good News From Pharma Pending More Visibility
February 11, 2015 at 07:54 AM EST
Achillion Pharmaceuticals Inc.'s (NASDAQ: ACHN) recent interim data for its developmental hepatitis C drug is "incrementally positive," ...
